133 related articles for article (PubMed ID: 37851456)
1. Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis.
Boesjes CM; van der Gang LF; Bakker DS; Ten Cate TA; Spekhorst LS; de Graaf M; van Dijk MR; de Bruin-Weller MS
JAMA Dermatol; 2023 Nov; 159(11):1240-1247. PubMed ID: 37851456
[TBL] [Abstract][Full Text] [Related]
2. Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates.
Sokumbi O; Shamim H; Davis MDP; Wetter DA; Newman CC; Comfere N
Am J Dermatopathol; 2021 Oct; 43(10):714-720. PubMed ID: 34132660
[TBL] [Abstract][Full Text] [Related]
3. Dupilumab-associated mycosis fungoides: a cross-sectional study.
Hamp A; Hanson J; Schwartz RA; Lambert WC; Alhatem A
Arch Dermatol Res; 2023 Nov; 315(9):2561-2569. PubMed ID: 37270763
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides with epidermal mucinosis: a variant of mycosis fungoides with a spongiosis-like pattern.
Hu SW; Ratech H; Naeem R; Latkowski JA; Kamino H
J Cutan Pathol; 2015 Oct; 42(10):730-8. PubMed ID: 26009972
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome.
Hirotsu KE; Neal TM; Khodadoust MS; Wang JY; Rieger KE; Strelo J; Hong E; Kim YH; Kwong BY
JAMA Dermatol; 2021 Jun; 157(6):700-707. PubMed ID: 33881447
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
8. Interface change in early mycosis fungoides: A potential mimicker of benign dermatoses.
Tsang M; McNiff JM
J Cutan Pathol; 2023 Mar; 50(3):266-274. PubMed ID: 36444501
[TBL] [Abstract][Full Text] [Related]
9. Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab.
Newsom M; Hrin ML; Hamid RN; Strowd LC; Ahn C; Jorizzo JL; Feldman SR
Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560800
[No Abstract] [Full Text] [Related]
10. Dupilumab-Associated Mycosis Fungoides with a CD8+ Immunophenotype.
Park A; Wong L; Lang A; Kraus C; Anderson N; Elsensohn A
Dermatopathology (Basel); 2022 Nov; 9(4):385-391. PubMed ID: 36547219
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of T-cell antigen losses in mycosis fungoides and CD30-positive cutaneous T-cell lymphoproliferations in a series of 153 patients.
Wechsler J; Ingen-Housz-Oro S; Deschamps L; Brunet-Possenti F; Deschamps J; Delfau MH; Calderaro J; Ortonne N
Pathology; 2022 Oct; 54(6):729-737. PubMed ID: 35577607
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
13. CD8(+) granulomatous cutaneous T-cell lymphoma: a potential association with immunodeficiency.
Gammon B; Robson A; Deonizio J; Arkin L; Guitart J
J Am Acad Dermatol; 2014 Sep; 71(3):555-60. PubMed ID: 24813299
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance related proteins in primary cutaneous lymphomas.
van Haselen CW; Flens MJ; Scheper RJ; van der Valk P; Scheffer GL; Toonstra J; van Vloten WA
Adv Exp Med Biol; 1999; 457():119-31. PubMed ID: 10500787
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
[TBL] [Abstract][Full Text] [Related]
16. Mycosis Fungoides Unmasked by Dupilumab Treatment in a Patient With a History of Atopic Dermatitis.
Ayasse M; Nelson K; Glass F; Silverberg JI
Dermatitis; 2021 Oct; 32(1S):e88-e89. PubMed ID: 33273230
[No Abstract] [Full Text] [Related]
17. Two cases of syringotropic cutaneous T-cell lymphoma and review of the literature.
Yost JM; Do TT; Kovalszki K; Su L; Anderson TF; Gudjonsson JE
J Am Acad Dermatol; 2009 Jul; 61(1):133-8. PubMed ID: 19539851
[TBL] [Abstract][Full Text] [Related]
18. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study.
Hasan I; Parsons L; Duran S; Zinn Z
J Am Acad Dermatol; 2024 Apr; ():. PubMed ID: 38588818
[TBL] [Abstract][Full Text] [Related]
20. A histo-immunopathologic and prognostic study of erythrodermic cutaneous T-cell lymphoma.
Vonderheid EC; Kantor GR; Telang GH; Bujanouskas P; Kadin ME
J Cutan Pathol; 2019 Dec; 46(12):913-924. PubMed ID: 31403211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
